ClinicalTrials.gov
public full text
Public Domain
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
This is a phase II double blind, placebo-controlled, randomized study of artesunate ointment for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antiretroviral therapy as a factor protective against anal dysplasia in HIV-infected males who have sex with males#647339
- HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)#909400
- Exploring Community Pharmacy Based Antiretroviral Therapy Refill for Stable HIV Patients in Tanzania#624442
- Association of baseline advanced HIV disease and dolutegravir versus non-dolutegravir regimen status with viral load suppression among patients on antiretroviral therapy in Tanzania#130531
- Association of baseline advanced HIV disease and dolutegravir versus non-dolutegravir regimen status with viral load suppression among patients on antiretroviral therapy in Tanzania#67993
Record · ID 894317
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive